CONGRESS GUIDE

ERS International Congress 2016
DETAILED PROGRAMME
MONDAY 05 SEPTEMBER, 2016
PA2671
The effectiveness of pulmonary TB treatment in patients with organic liver diseases, depending on the way of
administration of anti-TB drugs
Mykhailo Kuzhko (Kyiv, Ukraine), Mykhailo Kuzhko, Nataliia Hulchuk, Tetiana Tlustova, Oksana Avramchuk, Mykola
Gumeniuk
PA2672
Rifamycin induced leukocytoclastic vasculitis. A rare side-effect of anti-tuberculous chemotherapy
Alexandra Ewence (Salisbury, United Kingdom), Alexandra Ewence, Jessica Dodd, Angela Tewari, Victoria Akhras,
Raminder Aul
T-29 Session 402 12:50 - 14:40
Thematic Poster: Update on drug-resistant tuberculosis
Chairs : Elmira Ibraim (BUCURESTI, Romania), Lucy V. Baker (London, United Kingdom), Christoph Lange (Borstel, Germany), Marc
Lipman (London, United Kingdom)
PA2673
Programmatic management of drug resistance tuberculosis: Outcome analysis of 200 patients in western part of
Rajasthan, India
Sunil Kumar (Jodhpur, India), Sunil Kumar, Kailash Sharma, K.C. Agarwal, Swetabh Purohit
PA2674
PA2675
PA2676
PA2677
PA2678
PA2679
PA2680
PA2681
PA2682
PA2683
PA2684
PA2685
PA2686
Prevalence of rifampicin resistance by CB-NAAT in previously treated pulmonary tuberculosis cases
Mahendra kumar Bainara (Udaipur, India), Mahendra Kumar Bainara, Ananda Datta, Dinesh Kumar Sharma
Indicators of rifampicin-resistant TB response in Belarus, 2009-2014
Alena Skrahina (Minsk region, Belarus), Alena Skrahina, Hennadz Hurevich, Andrei Astrauko, Dzmitry Klimuk, Liudmila
Zhylevich, Valiantsin Rusovich, Masoud Dara, Andrei Dadu, Dennis Falzon
Rifampicin and INH monoresistance prevalence among Iraqi smear positive pulmonary tuberculosis cases
Mohammad Abdulrazaq (Bagdad, Iraq), Mohammad Abdulrazaq, Layth Salih, Ahmed Mankhi, Hayder Al-Sikafi, Hussain
Aldoori, Amar Zaidan, Samer Ameen, Talal Rajeb
Range of additional drug resistance of M.tuberculosis in XDR-TB patients
Irina Vasilyeva Anatolievna (Moscow, Russian Federation), Irina Vasilyeva Anatolievna, Anastasia Samoilova, Larisa
Chernousova, Tatev Bagdasaryan, Vadim Testov
Dynamics analysis of MBT drug resistance to antitubercolosis second-line drugs (Saratov region hospital, Russia)
Liudmila Pankratova (Saratov, Russian Federation), Liudmila Pankratova, Natalia Kazimirova, Inna Volchkova, Nikita
Navolokin
Study on drug sensitivity patterns in tuberculosis in tertiary care in Mumbai
Namrata Kewalramani (Mumbai, India), Namrata Saxena, Vikas Agarwal, Amita Nene
Particularities of a cohort of preXDR / XDR TB patients treated with group 5 medication, hospitalized in MDR TB
Department Institute of Pneumophtisiology Bucharest, Romania
Cristina Marcella Popa (BUCURESTI, Romania), Gilda Popescu, Cristina Popa, Victor Spinu, Popa Cristian
Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrugresistant
tuberculosis in Germany
Daniel Wirth (Neuss, Germany), Daniel Wirth, Ramesh Dass, Robert Hettle
Active drug-safety monitoring and management for tuberculosis patients treated with bedaquiline and linezolid,
Belarus – 2014-2016
Alena Skrahina (Minsk region, Belarus), Alena Skrahina, Hennadz Hurevich, Dzmitry Viatushka, Varvara Solodovnikova,
Dennis Falzon, Liudmila Zhylevich, Valiantsin Rusovich, Masoud Dara, Andrei Dadu, Pierpaolo de Colombani, George
Sakvarelidze, Svetlana Setkina
Treatment by linezolid of lung TB caused by drug resistant mycobacterium (MBT)
Mariya Pavlova (ST PETERSBURG, Russian Federation), Mariya Pavlova, Anna Starshinova, Irina Chernokhaeva,
Ekaterina Belyaeva, Nadezhda Sapozhnikova
Changes in MIRU-VNTR profiles are associated with treatment failures in tuberculosis patients
Irina Kontsevaya (London, United Kingdom), Irina Kontsevaya, Vladyslav Nikolayevskyy, Alexander Kovalyov, Olga
Ignatyeva, Edita Vasiliauskiene, Girts Skenders, Yanina Balabanova, Francis Drobniewski
Time to sputum culture conversion as a prognostic marker for end-of-treatment outcome in the first cohorts of
MDR-TB patients managed in a Nigerian tertiary hospital
Olusoji Ige (Ibadan, Oyo, Nigeria), Olusoji Ige, Regina Oladokun
Pattern of second line drug-resistance in MDR-TB treatment failure cases at a tertiary care tuberculosis treatment
centre in western region of India
Mani Tiwari (Allahabad, India), Mani Tiwari, Mahendra Patel
182 26.08.2016